Surgical Site Infections After Liver Transplantation Based on Perioperative Antibiotics
Liver Transplantation, Surgical Site Infection
About this trial
This is an interventional treatment trial for Liver Transplantation
Eligibility Criteria
Inclusion Criteria:
- All patients ≥ 18 years of age.
- Eligible for liver transplantation by UVA standard protocol.
- First-time transplantation.
- No active infections - requiring antibiotics - excluding antifungals.
Exclusion Criteria:
- All patients < 18 years of age.
- Previous liver transplantation.
- Active infections - requiring antibiotics.
- Allergy to all standard peri-operative antibiotics (piperacillin/tazobactam or UVA standard alternatives for Penicillin allergic patients: ciprofloxacin and vancomycin).
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
standard peri-operative antibiotics
extended three-day course of antibiotics
The standard of care at the University of Virginia Medical Center for liver transplantation patients is a 3.375 gram dose of piperacillin / tazobactam (Zosyn®) at the time of induction of anesthesia, though this dose may be adjusted for renal insufficiency. This dose is repeated during the operation every six hours.
For those patients randomized to the study group, antibiotics will be started as per the usual intra-operative dosing regimen, then continued to provide coverage for 72 hours. This is typically provided as additional doses of 3.375 grams of piperacillin / tazobactam (Zosyn®) every 8 hours for 3 total days (giving a total of 72 hours of antibiotic coverage), though this may be altered based on kidney function.